Download PDF
Thromb Haemost 2024; 124(01): 061-068
DOI: 10.1055/a-2127-0690
Stroke, Systemic or Venous Thromboembolism

The Report of Community-Based and Government-Endorsed Screening Program of Atrial Fibrillation in Taiwan

Tze-Fan Chao
1   Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
2   Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
,
Yung-Hsin Yeh
3   The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
4   College of Medicine, Chang Gung University, Taoyuan, Taiwan
,
Yi-Hsin Chan
3   The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
4   College of Medicine, Chang Gung University, Taoyuan, Taiwan
5   Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan
,
Fang-Ju Lin
6   Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
7   School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
8   Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan
,
Tien-Hsing Chen
4   College of Medicine, Chang Gung University, Taoyuan, Taiwan
9   Department of Cardiology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
,
Kuo-Li Pan
4   College of Medicine, Chang Gung University, Taoyuan, Taiwan
10   Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi, Taiwan
,
Jiunn-Cherng Lin
2   Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
11   Division of Cardiology, Taichung Veterans General Hospital, Chiayi branch, Chiayi, Taiwan
,
Yenn-Jiang Lin
1   Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
2   Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
,
Shih-Ann Chen
1   Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
2   Institute of Clinical Medicine and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
12   Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan
› Author Affiliations Funding This work was supported by grants from the Health Promotion Administration, Ministry of Health and Welfare, Taiwan and Taiwan Heart Rhythm Society.
› Further Information
Also available at
    Permissions and Reprints


Abstract

Background Although international guidelines recommended opportunistic screening for atrial fibrillation (AF), the community-based AF screening program incorporated into the government-endorsed health care system is rarely reported in Asian countries.

Objectives We aimed to test the feasibility of adding AF screening into the preexistent adult health check program and report the AF detection rate and percentages of OAC prescriptions before and after AF screening with the involvement of public health care systems.

Methods We performed this program in three counties (Chiayi county, Keelung City, and Yilan county) in Taiwan which have their own official preexistent adult health check programs conducted by public health bureaus for years. However, electrocardiography (ECG) was not included in these programs before. We cooperated with the public health bureaus of the three counties and performed single-lead 30-second ECG recording for every participant.

Results From January to December 2020, AF screening was performed in 199 sessions with 23,572 participants. AF was detected in 278 subjects with a detection rate of 1.19% (age ≥65 years: 2.39%; ≥75 years: 3.73%). The mean CHA2DS2-VASc score of these 278 subjects was 2.36, with 91% of them had a score ≥1 (males) or ≥2 (females). The number needed to screen was 42 and 27 for subjects aged ≥65 and ≥75 years, respectively. The prescription rate of OACs significantly increased from 11.4 to 60.6% in Chiayi county and from 15.8 to 50.0% in Keelung City after screening (both p-values <0.001).

Conclusion This community-based and government-endorsed AF screening project in Taiwan demonstrated that incorporation of AF screening into the preexistent adult health check programs through co-operations with the government was feasible. Actions to detect AF, good education, and well-organized transferring plan after AF being detected with the involvement of public health care systems could result in a substantial increase in the prescription rate of OACs.

Keywords

atrial fibrillation - screening - detection - government - oral anticoagulants


Publication History

Received: 03 May 2023

Accepted: 10 July 2023

Accepted Manuscript online:
11 July 2023

Article published online:
11 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Chao TF, Liu CJ, Tuan TC. et al. Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan Nationwide AF Cohort Study. Chest 2018; 153 (02) 453-466
    CrossrefPubMedSearch in Google Scholar
  • 2 Nicolajsen CW, Nielsen PB, Jensen M. et al. Stroke and myocardial infarction in patients with abdominal aortic aneurysm and new-onset atrial fibrillation. Thromb Haemost 2023; 123 (05) 555-564
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Chao TF, Joung B, Takahashi Y. et al. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation. J Arrhythm 2021; 37 (06) 1389-1426
    CrossrefPubMedSearch in Google Scholar
  • 4 Chao TF, Joung B, Takahashi Y. et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost 2022; 122 (01) 20-47
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Wallenhorst C, Martinez C, Freedman B. Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations. Thromb Haemost 2022; 122 (02) 277-285
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Proietti M, Boriani G. Screening for atrial fibrillation in relation to stroke and mortality risk. Thromb Haemost 2022; 122 (02) 171-175
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Chao TF, Tse HF, Teo WS. et al; Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Clinical utility and prognostic implications of the 4S-AF scheme: report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Eur J Clin Invest 2022; 52 (10) e13825
    CrossrefPubMedSearch in Google Scholar
  • 8 Af S, Collaborators A-E. AF SCREEN and AFFECT-EU Collaborators. Protocol for a systematic review and individual participant data meta-analysis of randomized trials of screening for atrial fibrillation to prevent stroke. Thromb Haemost 2023; 123 (03) 366-376
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Romiti GF, Guo Y, Corica B, Proietti M, Zhang H, Lip GYH. mAF-App II trial investigators. Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial. Thromb Haemost 2023; ( e-pub ahead of print).
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Hindricks G, Potpara T, Dagres N. et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42 (05) 373-498
    Search in Google Scholar
  • 11 Chan NY, Orchard J, Agbayani MJ. et al. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening. J Arrhythm 2021; 38 (01) 31-49
    CrossrefPubMedSearch in Google Scholar
  • 12 Chan PH, Wong CK, Pun L. et al. Head-to-head comparison of the AliveCor heart monitor and Microlife WatchBP Office AFIB for atrial fibrillation screening in a primary care setting. Circulation 2017; 135 (01) 110-112
    CrossrefPubMedSearch in Google Scholar
  • 13 Chan NY, Choy CC. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram. Heart 2017; 103 (01) 24-31
    CrossrefPubMedSearch in Google Scholar
  • 14 Chan NY, Choy CC, Chan CK, Siu CW. Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: an observational cohort study. Heart Rhythm 2018; 15 (09) 1306-1311
    CrossrefPubMedSearch in Google Scholar
  • 15 Lowres N, Olivier J, Chao TF. et al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Med 2019; 16 (09) e1002903
    CrossrefPubMedSearch in Google Scholar
  • 16 Sun W, Freedman B, Martinez C, Wallenhorst C, Yan BP. Atrial fibrillation detected by single time-point handheld electrocardiogram screening and the risk of ischemic stroke. Thromb Haemost 2022; 122 (02) 286-294
    Thieme ConnectPubMedSearch in Google Scholar